Literature DB >> 23598540

Fatty acid binding protein 4 predicts left ventricular mass and longitudinal function in overweight and obese women.

Stefan Engeli1, Wolfgang Utz, Sven Haufe, Valéria Lamounier-Zepter, Martin Pofahl, Julius Traber, Jürgen Janke, Friedrich C Luft, Michael Boschmann, Jeanette Schulz-Menger, Jens Jordan.   

Abstract

OBJECTIVE: To explore whether increased adipocyte-derived serum fatty acid binding protein 4 (FABP4) predisposes to cardiac remodelling and left ventricular dysfunction in human obesity.
DESIGN: Cross-sectional investigation.
SETTING: Academic clinical research centre. PATIENTS: 108 overweight and obese non-diabetic women (body-mass index 33 ± 5 kg/m2).
INTERVENTIONS: None. MAIN OUTCOME MEASURES: Relationship between serum FABP4 and abdominal adipose tissue quantified by MRI. Relationship between serum FABP4 and left ventricular morphology and function assessed by cardiac MRI.
RESULTS: FABP4 was independently associated with visceral abdominal adipose tissue (β=0.34, p<0.01) and subcutaneous abdominal adipose tissue (β=0.22, p<0.05). After stratification into serum FABP4 tertiles, left ventricular masses were 92 ± 16 g, 86 ± 13 g and 81 ± 12 g in women with high, intermediate and low FABP4 concentrations (p<0.01), respectively. Longitudinal systolic function was reduced by 8% in women with intermediate and high versus low FABP4 concentrations (p<0.01), whereas ejection fraction did not differ among tertiles (p=0.5). In multivariate linear analysis FABP4 remained an independent predictor of left ventricular mass (β=0.17, p<0.05) and reduced longitudinal fractional shortening (β=0.21, p<0.05).
CONCLUSIONS: In overweight and obese women, FABP4 showed an independent association with parameters of left ventricular remodelling.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23598540     DOI: 10.1136/heartjnl-2013-303735

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  16 in total

Review 1.  Mechanisms linking adipose tissue inflammation to cardiac hypertrophy and fibrosis.

Authors:  Sarah R Anthony; Adrienne R Guarnieri; Anamarie Gozdiff; Robert N Helsley; Albert Phillip Owens; Michael Tranter
Journal:  Clin Sci (Lond)       Date:  2019-11-29       Impact factor: 6.124

2.  Calcium-dependent release of adipocyte fatty acid binding protein from human adipocytes.

Authors:  I Schlottmann; M Ehrhart-Bornstein; M Wabitsch; S R Bornstein; V Lamounier-Zepter
Journal:  Int J Obes (Lond)       Date:  2013-12-19       Impact factor: 5.095

3.  Interaction of epoxyeicosatrienoic acids and adipocyte fatty acid-binding protein in the modulation of cardiomyocyte contractility.

Authors:  V Lamounier-Zepter; C Look; W-H Schunck; I Schlottmann; C Woischwill; S R Bornstein; A Xu; I Morano
Journal:  Int J Obes (Lond)       Date:  2014-11-05       Impact factor: 5.095

4.  Glucose induces sensitivity to oxygen deprivation and modulates insulin/IGF-1 signaling and lipid biosynthesis in Caenorhabditis elegans.

Authors:  Anastacia M Garcia; Mary L Ladage; Dennis R Dumesnil; Khadiza Zaman; Vladimir Shulaev; Rajeev K Azad; Pamela A Padilla
Journal:  Genetics       Date:  2015-03-10       Impact factor: 4.562

5.  Can the use of blood-based biomarkers in addition to anthropometric indices substantially improve the prediction of visceral fat volume as measured by magnetic resonance imaging?

Authors:  Jasmine Neamat-Allah; Theron Johnson; Diana Nabers; Anika Hüsing; Birgit Teucher; Verena Katzke; Stefan Delorme; Rudolf Kaaks; Tilman Kühn
Journal:  Eur J Nutr       Date:  2014-08-07       Impact factor: 5.614

6.  Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction.

Authors:  Julio A Chirinos; Alena Orlenko; Lei Zhao; Michael D Basso; Mary Ellen Cvijic; Zhuyin Li; Thomas E Spires; Melissa Yarde; Zhaoqing Wang; Dietmar A Seiffert; Stuart Prenner; Payman Zamani; Priyanka Bhattacharya; Anupam Kumar; Kenneth B Margulies; Bruce D Car; David A Gordon; Jason H Moore; Thomas P Cappola
Journal:  J Am Coll Cardiol       Date:  2020-03-24       Impact factor: 24.094

7.  Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population.

Authors:  Takahiro Fuseya; Masato Furuhashi; Satoshi Yuda; Atsuko Muranaka; Mina Kawamukai; Tomohiro Mita; Shutaro Ishimura; Yuki Watanabe; Kyoko Hoshina; Marenao Tanaka; Kohei Ohno; Hiroshi Akasaka; Hirofumi Ohnishi; Hideaki Yoshida; Shigeyuki Saitoh; Kazuaki Shimamoto; Tetsuji Miura
Journal:  Cardiovasc Diabetol       Date:  2014-08-21       Impact factor: 9.951

Review 8.  Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases.

Authors:  Masato Furuhashi; Shigeyuki Saitoh; Kazuaki Shimamoto; Tetsuji Miura
Journal:  Clin Med Insights Cardiol       Date:  2015-02-02

9.  Reverse differentiation as a gene filtering tool in genome expression profiling of adipogenesis for fat marker gene selection and their analysis.

Authors:  Mujib Ullah; Stefan Stich; Thomas Häupl; Jan Eucker; Michael Sittinger; Jochen Ringe
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

10.  Adipocyte fatty acid-binding protein levels are associated with left ventricular diastolic dysfunction in morbidly obese subjects.

Authors:  A Baessler; V Lamounier-Zepter; S Fenk; C Strack; C Lahmann; T Loew; G Schmitz; M Blüher; S R Bornstein; M Fischer
Journal:  Nutr Diabetes       Date:  2014-02-10       Impact factor: 5.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.